NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

8295	Companies
114877	Keywords
55312	Articles
62450	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 09/18/2024 at 22:15, 2 months 2 days ago

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
Nanobiotix updates on operational progress and reports Half Year 2024 financial results, showcasing clinical milestones and licensing agreements with Janssen. Cash reserves extended until Q4 2025

Financial Results Clinical Milestones NANOBIOTIX Half Year 2024 Janssen Agreement
PRESS RELEASE

published on 09/18/2024 at 22:15, 2 months 2 days ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024
Nanobiotix publie ses résultats financiers et présente les avancées de NBTXR3, une approche innovante en oncologie basée sur les nanoparticules. Nouvelles collaborations et perspectives de développement clinique

Résultats Financiers Oncologie NANOBIOTIX NBTXR3 Nanoparticules
BRIEF

published on 09/04/2024 at 22:20, 2 months 16 days ago

NANOBIOTIX renforce son Conseil de Surveillance avec deux ajouts clés

Biotechnologie Conseil De Surveillance NANOBIOTIX Dr Liu Anat Nachitz
BRIEF

published on 09/04/2024 at 22:20, 2 months 16 days ago

NANOBIOTIX Enhances Supervisory Board with Two Key Additions

Biotechnology Supervisory Board NANOBIOTIX Dr. Liu Anat Naschitz
PRESS RELEASE

published on 09/04/2024 at 22:15, 2 months 16 days ago

NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
Nanobiotix announces key additions to Supervisory Board - Dr. Margaret A. Liu & Ms. Anat Naschitz. Expertise to drive growth in nanophysics-based therapies for cancer & major diseases

Supervisory Board NANOBIOTIX Dr. Margaret A. Liu Ms. Anat Naschitz Nanophysics-based Therapies
BRIEF

published on 09/03/2024 at 22:20, 2 months 17 days ago

Nanobiotix présentera à la 26e conférence annuelle mondiale sur l'investissement de HC Wainwright

Biotechnologie Webcast Discussion Au Coin Du Feu NANOBIOTIX Conférence Sur L'investissement
BRIEF

published on 09/03/2024 at 22:20, 2 months 17 days ago

Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference

Biotechnology Webcast Fireside Chat NANOBIOTIX Investment Conference
PRESS RELEASE

published on 09/03/2024 at 22:15, 2 months 17 days ago

Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
Nanobiotix to present at H.C. Wainwright 26th Annual Global Investment Conference. Company management to participate in fireside chat on September 11, 2024

Biotechnology Cancer H.C. Wainwright NANOBIOTIX Global Investment Conference
PRESS RELEASE

published on 09/03/2024 at 22:15, 2 months 17 days ago

NANOBIOTIX PARTICIPERA À LA 26ÈME ÉDITION DE LA CONFÉRENCE ANNUELLE H.C. WAINWRIGHT GLOBAL INVESTMENT
Nanobiotix participera à la 26ème édition de la conférence H.C. Wainwright Global Investment avec Laurent Levy et Bart Van Rhijn comme participants. Détails de l'événement ci-dessous

Investissement Biotechnologie Conference Cancer NANOBIOTIX
BRIEF

published on 08/08/2024 at 22:20, 3 months 12 days ago

Nanobiotix: Information on Voting Rights and Shares as of July 31, 2024

Share Capital Voting Rights Actions Sotck Exchange NANOBIOTIX

Accesswire

Published on 11/21/2024 at 13:00, 11 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 11 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 11 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 11 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 11 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 36 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 56 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 4 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 11 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 41 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 13 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 13 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 13 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 3 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 51 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE